Alpha Teknova, Inc. Announces Termination of Certain Executive Officers, Effective from March 1, 2024
January 16, 2024 at 05:15 pm EST
Share
Alpha Teknova, Inc. informed Ken Gelhaus, its Chief Commercial Officer, and Lisa McCann, its Chief People Officer, that their employment with the Company would end at the close of business on March 1, 2024, because the Company had decided to eliminate the roles of Chief Commercial Officer and Chief People Officer. Each of Mr. Gelhaus and Ms. McCann agreed to stay with the Company through March 1, 2024, in the interests of a smooth transition. The Company thanks Mr. Gelhaus and Ms. McCann for their many valuable contributions.
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
ALPHA TEKNOVA, INC. 
